IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDXX Financials

SEC Filings

IDXX Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
2.759B722.739M658.114M683.354M694.732M623.379M570.660M596.038M620.880M
4.446B1.141B1.091B1.105B1.109B998.427M954.288M975.543M1.004B
Cost of Goods Sold
1.687B418.081M432.465M421.885M414.725M375.048M383.628M379.505M382.698M
63.4%63.4%60.3%61.8%62.6%62.4%59.8%61.1%61.9%
Total Operating Expenses
1.353B360.153M342.509M328.508M321.686M306.845M308.974M292.146M355.358M
257.934M65.788M66.833M63.415M61.898M59.061M57.729M53.978M55.450M
1.095B294.365M275.676M265.093M259.788M247.784M251.245M238.168M299.908M
1.406B362.586M315.605M354.846M373.046M316.534M261.686M303.892M263.801M
31.8%31.8%28.9%32.1%33.6%31.7%27.4%31.2%26.3%
1.370B355.442M306.982M344.771M362.352M310.084M256.387M298.909M259.056M
Interest Income
1.794M587K580K627K1.216M2.199M2.714M3.354M
39.636M7.144M10.516M10.655M11.321M7.666M7.498M7.697M8.099M
Other Income/Expense
-36.536M-7.144M-8.623M-10.075M-10.694M-6.450M-5.299M-4.983M-4.745M
1.095B278.446M248.188M274.610M293.989M242.677M216.149M232.841M203.298M
274.314M76.996M58.794M70.161M68.363M67.407M40.238M66.068M55.758M
24.4%24.4%22.8%24.8%26.5%24.3%22.7%23.9%20.3%
1.520B362.586M356.219M392.053M409.445M351.813M298.563M341.999M300.727M
EBITDA Margin
31.8%31.8%32.7%35.5%36.9%35.2%31.3%35.1%30.0%
111.120M0.0038.721M36.627M35.772M34.063M33.706M34.133M32.193M
EPS Basic
13.673.483.103.433.662.982.632.832.46
13.563.453.083.403.632.962.622.802.44
Shares Outstanding
80.096M80.096M80.096M80.096M80.413M81.319M81.846M82.304M82.630M
Diluted Shares Outstanding
80.675M80.675M80.675M80.675M80.994M81.922M82.538M83.056M83.393M

IDXX Annual Income Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
2.660B2.379B2.190B2.004B1.889B1.571B1.366B1.242B
4.304B3.898B3.661B3.367B3.215B2.707B2.407B2.213B
Cost of Goods Sold
1.644B1.519B1.471B1.363B1.326B1.136B1.041B971.700M
61.8%61.0%59.8%59.5%58.8%58.0%56.7%56.1%
Total Operating Expenses
1.300B1.251B1.093B1.106B957.404M876.516M812.703M750.207M
251.207M219.792M190.951M254.820M161.009M141.249M133.193M117.863M
1.048B1.031B901.891M850.753M796.395M735.267M679.510M632.344M
1.360B1.128B1.097B898.765M932.028M694.524M552.846M491.335M
31.6%29.0%30.0%26.7%29.0%25.7%23.0%22.2%
1.324B1.110B1.061B859.972M902.654M661.985M522.218M457.742M
Interest Income
2.423M12.699M5.629M1.065M434K586K427K1.151M
38.265M31.205M41.581M39.858M29.808M33.125M31.055M34.744M
Other Income/Expense
-35.842M-18.506M-35.952M-38.793M-29.374M-32.539M-30.628M-33.593M
1.059B887.867M845.042M679.089M744.845M581.776M427.720M377.031M
264.725M221.964M216.134M180.883M157.810M79.854M94.426M80.695M
24.6%22.8%23.1%20.2%23.2%21.5%17.8%17.0%
1.469B1.276B1.218B1.015B1.040B793.808M643.684M575.664M
EBITDA Margin
34.1%32.7%33.3%30.1%32.3%29.3%26.7%26.0%
106.462M129.936M114.908M111.900M104.596M95.998M88.011M83.178M
EPS Basic
13.1710.7710.178.128.746.824.974.34
13.0810.6710.068.038.606.714.894.26
Shares Outstanding
80.096M82.467M83.066M83.623M85.200M85.342M86.115M86.864M
Diluted Shares Outstanding
80.675M83.246M83.978M84.600M86.572M86.722M87.542M88.470M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky